151 related articles for article (PubMed ID: 9167186)
1. Increased plasma serotonin following treatment with flavone-8-acetic acid, 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: relation to vascular effects.
Baguley BC; Zhuang L; Kestell P
Oncol Res; 1997; 9(2):55-60. PubMed ID: 9167186
[TBL] [Abstract][Full Text] [Related]
2. Tumor-dependent increased plasma nitrate concentrations as an indication of the antitumor effect of flavone-8-acetic acid and analogues in mice.
Thomsen LL; Ching LM; Zhuang L; Gavin JB; Baguley BC
Cancer Res; 1991 Jan; 51(1):77-81. PubMed ID: 1988109
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid.
Thomsen LL; Ching LM; Baguley BC
Cancer Res; 1990 Nov; 50(21):6966-70. PubMed ID: 2170013
[TBL] [Abstract][Full Text] [Related]
4. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.
Mahadevan V; Malik ST; Meager A; Fiers W; Lewis GP; Hart IR
Cancer Res; 1990 Sep; 50(17):5537-42. PubMed ID: 2386959
[TBL] [Abstract][Full Text] [Related]
5. Flavone acetic acid increases the antitumor effect of hyperthermia in mice.
Sakaguchi Y; Maehara Y; Baba H; Kusumoto T; Sugimachi K; Newman RA
Cancer Res; 1992 Jun; 52(12):3306-9. PubMed ID: 1596889
[TBL] [Abstract][Full Text] [Related]
6. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy.
Evelhoch JL; Bissery MC; Chabot GG; Simpson NE; McCoy CL; Heilbrun LK; Corbett TH
Cancer Res; 1988 Sep; 48(17):4749-55. PubMed ID: 3409216
[TBL] [Abstract][Full Text] [Related]
7. Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo.
Bissery MC; Valeriote FA; Chabot GG; Crissman JD; Yost C; Corbett TH
Cancer Res; 1988 Mar; 48(5):1279-85. PubMed ID: 3422592
[TBL] [Abstract][Full Text] [Related]
8. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice.
Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD
Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic and pharmacokinetic relationships of flavone acetic acid: an agent with activity against solid tumors.
Zaharko DS; Grieshaber CK; Plowman J; Cradock JC
Cancer Treat Rep; 1986 Dec; 70(12):1415-21. PubMed ID: 3791254
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma.
Sun JR; Brown JM
Cancer Res; 1989 Oct; 49(20):5664-70. PubMed ID: 2790784
[TBL] [Abstract][Full Text] [Related]
11. The role of immune effector cells in flavone acetic acid-induced injury to tumor cells in EMT6 spheroids.
Zwi LJ; Baguley BC; Gavin JB; Holdaway KM; Wilson WR
Oncol Res; 1992; 4(8-9):333-9. PubMed ID: 1486217
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics of the antitumour agents 5,6-dimethylxanthenone-4-acetic acid, xanthenone-4-acetic acid and flavone-8-acetic acid in mice.
McKeage MJ; Kestell P; Denny WA; Baguley BC
Cancer Chemother Pharmacol; 1991; 28(6):409-13. PubMed ID: 1934244
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice.
Cummings J; Double JA; Bibby MC; Farmer P; Evans S; Kerr DJ; Kaye SB; Smyth JF
Cancer Res; 1989 Jul; 49(13):3587-93. PubMed ID: 2731178
[TBL] [Abstract][Full Text] [Related]
14. Haematological effects in mice of the antitumour agents xanthenone-4-acetic acid, 5,6-dimethyl-xanthenone-4-acetic acid [correction of 5,6-methyl-] and flavone acetic acid.
Ching LM; McKeage MJ; Joseph WR; Kestell P; Zwi LJ; Baguley BC
Cancer Chemother Pharmacol; 1991; 28(6):414-9. PubMed ID: 1934245
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
Thomsen LL; Baguley BC; Wilson WR
Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
[TBL] [Abstract][Full Text] [Related]
16. Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid.
Kal HB; de Graaff E; Van Berkel AH; Goedoen HH
In Vivo; 1992; 6(1):73-5. PubMed ID: 1385730
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.
Chabot GG; Bissery MC; Corbett TH; Rutkowski K; Baker LH
Cancer Chemother Pharmacol; 1989; 24(1):15-22. PubMed ID: 2597279
[TBL] [Abstract][Full Text] [Related]
18. Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives.
Futami H; Eader L; Back TT; Gruys E; Young HA; Wiltrout RH; Baguley BC
J Immunother (1991); 1992 Nov; 12(4):247-55. PubMed ID: 1477076
[TBL] [Abstract][Full Text] [Related]
19. Response of primary tumour, spontaneous metastases and recurrence of Lewis lung carcinoma (3LL) to flavone acetic acid (FAA, LM975).
Desoize B; Carpentier Y; Guerrier D
Anticancer Res; 1989; 9(6):1701-5. PubMed ID: 2627123
[TBL] [Abstract][Full Text] [Related]
20. [Immunosuppressive properties of vinblastine and colchicine].
Leont'eva TI; Maksimova GF; Babichev VA; Uteshev BS
Tsitologiia; 1977 Feb; 19(2):186-91. PubMed ID: 18824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
